Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
19.83
-0.21 (-1.05%)
Dec 20, 2024, 4:00 PM EST - Market closed
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.40 billion as of December 20, 2024. Its market cap has increased by 238.72% in one year.
Market Cap
1.40B
Enterprise Value
974.30M
1-Year Change
238.72%
Ranking
Category
Stock Price
$19.83
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.40B, an increase of 99.50%. That is a compound annual growth rate of 16.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.40B | 180.62% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kiniksa Pharmaceuticals International, | 1.48B |
| AtriCure | 1.47B |
| InMode | 1.45B |
| Indivior | 1.45B |
| Immunocore Holdings | 1.42B |
| Arcus Biosciences | 1.41B |
| Schrödinger | 1.41B |
| Novavax | 1.39B |